2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

• Published in: Circulation (New York, N.Y.) Vol. 142; no. 25; pp. e533 - e557
• Main Authors: Ommen, Steve R., Mital, Seema, Burke, Michael A., Day, Sharlene M., Deswal, Anita, Elliott, Perry, Evanovich, Lauren L., Hung, Judy, Joglar, José A., Kantor, Paul, Kimmelstiel, Carey, Kittleson, Michelle, Link, Mark S., Maron, Martin S., Martinez, Matthew W., Miyake, Christina Y., Schaff, Hartzell V., Semsarian, Christopher, Sorajja, Paul
• Format: Journal Article
• Language: English
• Published: United States by the American College of Cardiology Foundation and the American Heart Association, Inc 22.12.2020
• Subjects: occupation; risk stratification; echocardiography; systolic dysfunction; sudden cardiac death; left ventricular outflow tract obstruction; septal alcohol ablation; AHA Scientific Statements; sarcomeric genes; atrial fibrillation; genetics; shared decision-making; guidelines; family screening; rhythm monitoring; pregnancy; septal reduction therapy; cardiovascular magnetic resonance; physical activity; exercise stress testing; implantable cardioverter defibrillator; surgical myectomy; ventricular arrhythmias; diastolic dysfunction; hypertrophic cardiomyopathy

AIMThis executive summary of the hypertrophic cardiomyopathy clinical practice guideline provides recommendations and algorithms for clinicians to diagnose and manage hypertrophic cardiomyopathy in adult and pediatric patients as well as supporting documentation to encourage their use. METHODSA comp...